CONMED CNMD Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Product | |||||
| General Surgery | $800.13M+4.9% | $763.03M+7.2% | $711.59M+21.9% | $583.94M+2.1% | |
| Orthopedic Surgery | $574.6M+5.6% | $543.99M+2.0% | $533.16M+15.5% | $461.53M+5.3% | |
| Net Sales by Geography | |||||
| Americas (excluding the United States) | $126.76M+4.7% | $121.04M+0.1% | $120.93M+14.0% | $106.11M+9.2% | |
| Asia Pacific | $208.72M+7.2% | $194.68M-1.4% | $197.4M+21.5% | $162.48M-5.1% | |
| Europe, Middle East & Africa | $264.65M+8.9% | $243.06M+7.4% | $226.25M+14.3% | $197.94M+4.3% | |
| United States | $774.59M+3.5% | $748.22M+6.9% | $700.16M+20.9% | $578.95M+4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CONMED break its business down?
- CONMED (CNMD) reports net sales by product across 2 parts — General Surgery and Orthopedic Surgery. Each is extracted from the segment footnotes and tracked over time.
- Where does CONMED's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CONMED's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
